Last updated 2026-06-18
Total raised
—
Last: Undisclosed Round 2022-04
Stage
Series A
Founded
2013
Headcount
—
HQ
Yavne, Israel
Sector
Health Tech & Life Sciences
About
Metabomed is a drug-discovery company in the field of cancer metabolism, with a proprietary target-identification platform based on computational biology and metabolomics. The company focuses on developing drugs that inhibit targets that form a synthetic lethal gene pair with metabolic genes inactivated in cancer cells. Using this target-inhibiting strategy, Metabomed intends to develop more selective, highly focused anticancer drugs with the ability to kill cancer cells without harming normal cells.
Offices
Yavne, Israel · HQ / main office
Show all offices (1 more)
- Cambridge, United States
Q&A
- What is Metabomed's current operational status?
- Metabomed is currently inactive and ceased to operate in May 2024.
- What is Metabomed's primary focus?
- Metabomed is a drug-discovery company focused on cancer metabolism, developing drugs that inhibit targets forming a synthetic lethal gene pair with metabolic genes inactivated in cancer cells.
- When was Metabomed founded?
- Metabomed was founded in October 2013.
- How much funding has Metabomed raised in total?
- Metabomed has raised a total of $30,500,000 USD.
- Which investors participated in Metabomed's April 2016 funding round?
- In April 2016, Metabomed received funding from M Ventures and Pontifax.
- Which investor led Metabomed's December 2019 funding round?
- Metabomed's December 2019 funding round was led by Yonjin Ventures.
- Where is Metabomed's headquarters located?
- Metabomed's headquarters is located in Yavne, Israel.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCellsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
pharma-companiestargeted-therapyoncologybiotechnologybiopharmaceuticalcancerdrug-discoverygenomics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/9341600 |
Identifiers & details
| Founded | 2013-10 |
|---|---|
| Offices | Cambridge |
| Status reason | Non Active, May 2024 ceased to operate |